Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study

Archive ouverte

Breillat, Paul | Jachiet, Marie | Ditchi, Yoan | Lenormand, Cédric | Costedoat-Chalumeau, Nathalie | Mathian, Alexis | Moguelet, Philippe | Duriez, Paul | Trendelenburg, Marten | Huynh-Do, Uyen | Chizzolini, Carlo | Beuvon, Clément | Roy-Peaud, Frederique | Bouaziz, Jean-David | Barbaud, Annick | Francès, Camille | Mékinian, Arsène | Fain, Olivier | Amoura, Zahir | Chasset, François | Bessis, Didier | Cordel, Nadège | Lipsker, Dan | Cassius, Charles | Ribi, Camillo

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Abstract Objectives To describe the clinical and pathological features of biopsy-proven cutaneous vasculitis (CV) associated with SLE, focusing on diagnosis classification and impact on overall SLE activity. Methods Retrospective multicentric cohort study including SLE patients with biopsy-proven CV identified by (i) data from pathology departments of three university hospitals and (ii) a national call for cases. SLE was defined according to 1997 revised ACR and/or 2019 ACR/EULAR criteria. CV diagnosis was confirmed histologically and classified by using the dermatological addendum of the Chapel Hill classification. SLE activity and flare severity at the time of CV diagnosis were assessed independently of vasculitis items with the SELENA-SLEDAI and SELENA-SLEDAI Flare Index. Results Overall, 39 patients were included; 35 (90%) were female. Cutaneous manifestations included mostly palpable purpura (n = 21; 54%) and urticarial lesions (n = 18; 46%); lower limbs were the most common location (n = 33; 85%). Eleven (28%) patients exhibited extracutaneous vasculitis. A higher prevalence of Sjögren’s syndrome (51%) was found compared with SLE patients without CV from the French referral centre group (12%, P < 0.0001) and the Swiss SLE Cohort (11%, P < 0.0001). CV was mostly classified as urticarial vasculitis (n = 14, 36%) and cryoglobulinaemia (n = 13, 33%). Only 2 (5%) patients had no other cause than SLE to explain the CV. Sixty-one percent of patients had inactive SLE. Conclusion SLE-related vasculitis seems very rare and other causes of vasculitis should be ruled out before considering this diagnosis. Moreover, in more than half of patients, CV was not associated with another sign of active SLE.

Suggestions

Du même auteur

Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study

Archive ouverte | Cesbron, Elise | CCSD

International audience

Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients

Archive ouverte | Aitmehdi, Raphael | CCSD

International audience

Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity

Archive ouverte | Chasset, François | CCSD

International audience. No abstract available

Chargement des enrichissements...